Pfizer Receives Warning Letter from FDA
Pfizer received a warning letter last month from the FDA because of the company’s failure to report complaints promptly. The agency warned Pfizer about its failure to promptly report complaints associated with its drugs that may have involved serious injuries. Pfizer repeatedly failed to submit product complaints to the FDA within the required 15-day regulatory scheme. In some cases, Pfizer failed to include reports of serious side effects with the cholesterol drug Lipitor and the anti-seizure drug Lyrica.